IDEX Q4 sales rise 4% to $899 million; 2026 adjusted EPS outlook $8.15 to $8.35
IDEX reported fourth-quarter 2025 net sales of $899.1 million, up 4% on a reported basis and 1% organically, with reported diluted EPS of $1.71, up 6%. For full year 2025, sales rose 6% to $3.5 billion, but reported diluted EPS fell 3% to $6.41, while adjusted diluted EPS rose 1% to $7.95. The company also projected 2026 adjusted diluted EPS of $8.15 to $8.35.
Key points
- Q4 2025 net sales $899.1 million, up 4% reported and 1% organic; Q4 reported diluted EPS $1.71, up 6%
- Full year 2025 net sales $3,457.5 million, up 6%; reported diluted EPS $6.41, down 3%
- Full year 2025 adjusted diluted EPS $7.95, up 1%; operating cash flow $680.4 million
- 2026 outlook: full year adjusted diluted EPS $8.15 to $8.35; full year organic sales up 1% to 2%
The filing
Written by AI on Nov 8, 2026, 1:11 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on February 04, 2026.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.